anti-inflammatory-therapies | Media Room | PressRelease.com

Tagged anti-inflammatory-therapies

GB Sciences' First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson's Disease Has Been Issued in China

Press Release Mar 20, 2023

GB Sciences' First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson's Disease Has Been Issued in China

According to Statista, China has the second largest pharmaceutical market in the world and plant-based medicines are very well accepted, which makes China a potential target market for Gb Sciences. Read More

Successful 2022 Milestones Support Value of Gb Sciences' AI-Enabled Drug Discovery Platform

Press Release Mar 7, 2023

Successful 2022 Milestones Support Value of Gb Sciences' AI-Enabled Drug Discovery Platform

Biopharmaceutical research company specializing in cannabis- and plant-inspired medicines shares strategic plan for 2023 and key developments from 2022 Read More

Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform

Press Release Dec 22, 2022

Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform

Gb Sciences' innovative approach harnesses the power of plant-based treatments as simplified mixtures that target dangerous hyperinflammatory responses to viral infections. Read More

First
Prev

1

Next
Last